DGAP-News: RHÖN-KLINIKUM AG: Interim Report for the Third Quarter of 2017: RHÖN-KLINIKUM AG on the Right Track - Action Plan for Improving Profitability Successfully Commenced - Forecast for 2017 Confirmed

Nachricht vom 10.11.2017 (www.4investors.de) -


DGAP-News: RHÖN-KLINIKUM AG / Key word(s): 9-month figures/9-month figures

RHÖN-KLINIKUM AG: Interim Report for the Third Quarter of 2017: RHÖN-KLINIKUM AG on the Right Track - Action Plan for Improving Profitability Successfully Commenced - Forecast for 2017 Confirmed
10.11.2017 / 06:52


The issuer is solely responsible for the content of this announcement.
Corporate News

Interim Report for the Third Quarter of 2017:RHÖN-KLINIKUM AG on the Right Track - Action Plan for Improving Profitability Successfully Commenced - Forecast for 2017 Confirmed
 

- 208,703 patients treated

- Revenues amount to Euro 304.0 million

- EBITDA stands at Euro 27.4 million

- Outlook for 2017: Revenues between Euro 1.20 billion and Euro 1.23 billion;
  EBITDA between Euro 85 million and Euro 105 million

 

Bad Neustadt / Saale, 10th November 2017. RHÖN-KLINIKUM AG, one of the largest healthcare providers in Germany, treated 3.7 percent more patients in the third quarter of the current financial year than in the same quarter of last year. Revenues rose by 3.2 percent to Euro 304.0 million (previous year: Euro 294.7 million). Despite this positive development earnings before interest, taxes, depreciation and amortisation (EBITDA) stand slightly lower at Euro 27.4 million (previous year: Euro 28.1 million).

RHÖN-KLINIKUM AG CEO Stephan Holzinger showed fighting spirit for the coming months: "We shall continue to tackle the tasks ahead of us in a resolute manner in order to improve our profitability. In July we developed an extensive action plan with clear areas of responsibility and a tight schedule. We shall put this action plan into practice throughout the corporate group and expect to see initial operative improvements in 2018 already."

The many objections by the Medical Review Board of the Statutory Health Insurance Funds (Medizinischer Dienst der Krankenversicherungen - MDK) which either considerably delay or even refuse remuneration for services rendered and therefore ultimately reduce earnings are contrasted by the hospital group's package of measures: rigorous trainee programmes, documentation and the use of intelligent software to reduce the number of such objections and thus gradually increase revenues.

Furthermore the cost-effectiveness of all the major maintenance agreements for our hospitals is currently under review, the volume of material purchases will be bundled in order to benefit from economies of scale and the range of materials used is being scaled down to an appropriate amount. On the medical side the occupancy in complex core areas (e.g. intermediate care wards) is also being analysed and optimised in order to reduce inappropriate occupancy in costly areas.

"As well as the necessary improvement of our operative business we still have our sights firmly on our strategic challenges, expanding the RHÖN campus as a business model to provide excellent medical care in rural areas and digitalising our services and processes. The company is well-equipped in this regard and on schedule," Holzinger stated.

The innovative RHÖN campus concept is directed towards eliminating the hitherto hard boundary between in-patient and out-patient medical services and will combine the various services for our patients at one single site. State-of-the-art digital instruments are used here - both for the benefit of patients as well as employees. The hospital group sees considerable potential here to position itself as a provider of full-service healthcare and as a leading innovator in the healthcare market. The new campus in Bad Neustadt will open at the end of 2018 including a record amount of digitalisation.

Outlook

The company confirms its forecast for the current financial year of 2017 and expects revenues of between Euro 1.20 billion and Euro 1.23 billion and earnings before interest, taxes, depreciation and amortisation (EBITDA) of between Euro 85 million and Euro 105 million. This includes negative effects in a low two-digit million figure due to additional expense from digitalising medical processes and one-off burdens from group restructuring. We also currently assume that we shall be able to conclude the contractual settlement of the separate accounting for the Universities of Giessen and Marburg in the fourth quarter of 2017. We expect EBITDA to be within the upper half of the range when full legal ratification takes place.
___________________________________________________________________________

RHÖN?KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers cutting-edge medical care with a direct link to universities and research institutes. More than 800,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where approx. 16,500 employees work.

With the RHÖN campus the Company is currently implementing a new and forward-looking project which raises fully comprehensive healthcare in rural areas to a new level of excellence and is geared to the growing needs of patients. www.rhoen-klinikum-ag.comYour Contact Person:
RHÖN-KLINIKUM AG
Kai Knitter | Group Division Head of Corporate Communication and Investor Relations
Schlossplatz 1, D-97616 Bad Neustadt/Saale
Telephone: +49 9771 65-1328 | Mobile: +49 151 7305 1254 | Facsimile: +49 9771 65-1820
E-Mail: kai.knitter@rhoen-klinikum-ag.com

 











10.11.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:
English
Company:
RHÖN-KLINIKUM AG

Salzburger Leite 1

97616 Bad Neustadt a.d.Saale


Germany
Phone:
+49 (0)9771 - 65-0
Fax:
+49 (0)9771 - 97 467
E-mail:
rka@rhoen-klinikum-ag.com
Internet:
www.rhoen-klinikum-ag.com
ISIN:
DE0007042301
WKN:
704230
Indices:
SDAX
Listed:
Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange

 
End of News
DGAP News Service




627543  10.11.2017 





(Werbung)
PfeilbuttonOhne Depotgebühren. Mit Kosten-Airbag. Das Wertpapierdepot der MERKUR BANK.

4investors Exklusiv-Berichte und Interviews:
PfeilbuttonStern Immobilien: In den attraktivsten Nischenmärkten Europas tätig
PfeilbuttonPNE Wind: Lesser sieht „attraktive Opportunitäten für Zukäufe“
PfeilbuttonIPO-Kandidat STEMMER IMAGING AG: „Wir wollen den europäischen Markt weiter konsolidieren“

Aktuelle Nachrichten aus der 4investors-Redaktion

19.02.2018 - United Labels springt in die schwarzen Zahlen
19.02.2018 - mybet: Hauptversammlung macht Weg frei für Kapitalmaßnahme
19.02.2018 - GEA: Auftrag aus der Lithiumbranche
19.02.2018 - K+S: Erfolg vor Gericht
19.02.2018 - Linde will 7 Euro Dividende je Aktie zahlen
19.02.2018 - Siemens: Börsengang nimmt Form an
19.02.2018 - TLG Immobilien kauft Bürohaus in Eschborn
19.02.2018 - KAP Beteiligung steigert Umsatz und Gewinn
19.02.2018 - Consus: Finanzvorstand verstorben
19.02.2018 - Steinhoff Aktie: Ein interessanter Blick auf den Aktienkurs


Chartanalysen

19.02.2018 - Steinhoff Aktie: Ein interessanter Blick auf den Aktienkurs
19.02.2018 - Bitcoin Group Aktie: Neuer Schwung für die Kurserholung?
19.02.2018 - Daimler Aktie unter Druck: Was ist hier los?
19.02.2018 - Nordex Aktie: Starke Nerven sind gefragt
16.02.2018 - QSC Aktie: Bodenbildung voraus?
16.02.2018 - Paragon Aktie: Kommt jetzt die Kursrallye?
15.02.2018 - Wirecard Aktie: „Insiderkauf” beflügelt! Durchbruch nach oben?
15.02.2018 - Aixtron Aktie: Die nächsten Kaufsignale sind möglich!
15.02.2018 - 4SC Aktie: Was ist hier los?
14.02.2018 - Steinhoff Aktie: Neue Sorgen!


Analystenschätzungen

19.02.2018 - Mensch und Maschine: Neues Kaufrating
19.02.2018 - Klassik Radio: Coverage startet – Starke Kursentwicklung
19.02.2018 - Infineon: Weiteres Aufwärtspotenzial
19.02.2018 - QSC: Keine Sorge vor den Zahlen
19.02.2018 - Dialog Semiconductor: Intakte Situation
19.02.2018 - Ströer: Im Wachstumsmodus
19.02.2018 - Daimler: Kurs gerät nach US-Meldung unter Druck
19.02.2018 - Vossloh: Kursziel gerät stark unter Druck
19.02.2018 - Fresenius: Die Dollarschwäche wirkt sich aus
19.02.2018 - Allianz: Ein leichtes Plus


Kolumnen

19.02.2018 - Allianz Aktie: Kurzfristig weiteres Aufwärtspotenzial vorhanden - UBS Kolumne
19.02.2018 - DAX: Fortsetzung der Erholung stimmt positiv - UBS Kolumne
19.02.2018 - DAX: Weiterhin Stabilisierung nach gesundem Abverkauf - Donner + Reuschel Kolumne
16.02.2018 - Lufthansa Aktie: Mittelfristiger Abwärtstrend bleibt intakt - UBS Kolumne
16.02.2018 - DAX: Erholung setzt sich nur zögernd fort - UBS Kolumne
15.02.2018 - Übernahme- und Fusionsfieber - Commerzbank Kolumne
15.02.2018 - Vierte Leitzinserhöhung durch die US-Notenbank wird immer wahrscheinlicher- National-Bank Kolumne
15.02.2018 - Daimler Aktie: Erholung könnte sich fortsetzen - UBS Kolumne
15.02.2018 - DAX: Die Kursschwankungen bleiben hoch - UBS Kolumne
14.02.2018 - US-Einzelhandel: Kälte als Belastungsfaktor - Nord LB Kolumne

Werbung

All Right Reserved by minimalthemes - ©2018 Stoffels & Barck GbR